Results 31 to 40 of about 152 (81)

Cutaneous drug reaction secondary to antitubercular regimen: A case report from Nepal. [PDF]

open access: yesSAGE Open Med Case Rep, 2023
Bhattarai HB   +9 more
europepmc   +1 more source

Editorial: Case reports in dermatology. [PDF]

open access: yesFront Med (Lausanne), 2023
Recke A, Hashimoto T.
europepmc   +1 more source

Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions. [PDF]

open access: yesJ Clin Tuberc Other Mycobact Dis, 2023
Veenstra S   +10 more
europepmc   +1 more source

Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19). [PDF]

open access: yesJ Eur Acad Dermatol Venereol, 2022
Ben Salem C   +5 more
europepmc   +1 more source

Chlorthalidone-Induced Fixed-Drug Eruption: Unmasking an Uncommon Reaction to a Common Diuretic. [PDF]

open access: yesCureus, 2023
Marrero Castillo M   +6 more
europepmc   +1 more source

A 10-year retrospective cross-sectional study of severe cutaneous adverse drug reactions in Thailand: Human leukocyte antigen typing and enzyme-linked immunospot assay-assisted drug identification. [PDF]

open access: yesJAAD Int
Wongtada C   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy